ETC
BMRN icon

Exchange Traded Concepts’s BioMarin Pharmaceuticals BMRN Stock Holding History

Exchange Traded Concepts’s Portfolio BMRN Stock Details BMRN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.14M Buy
19,898
+2,644
+15% +$145K 0.01% 888
2026
Q1 		$975K Sell
17,254
-15,413
-47% -$899K 0.01% 820
2025
Q4 		$1.94M Buy
32,667
+7,501
+30% +$408K 0.01% 599
2025
Q3 		$1.36M Buy
25,166
+3,549
+16% +$203K 0.01% 670
2025
Q2 		$1.19M Buy
21,617
+1,821
+9% +$107K 0.01% 624
2025
Q1 		$1.4M Buy
19,796
+979
+5% +$65.9K 0.02% 459
2024
Q4 		$1.24M Buy
18,817
+2,154
+13% +$144K 0.02% 499
2024
Q3 		$1.17M Buy
16,663
+7,760
+87% +$649K 0.03% 461
2024
Q2 		$733K Sell
8,903
-124
-1% -$10.3K 0.02% 549
2024
Q1 		$788K Buy
9,027
+810
+10% +$72.5K 0.02% 493
2023
Q4 		$792K Sell
8,217
-1,855
-18% -$164K 0.02% 450
2023
Q3 		$891K Sell
10,072
-1,712
-15% -$152K 0.03% 414
2023
Q2 		$1.02M Buy
11,784
+639
+6% +$60.1K 0.03% 387
2023
Q1 		$1.08M Buy
11,145
+20
+0.2% +$2.07K 0.03% 316
2022
Q4 		$1.15M Sell
11,125
-1,487
-12% -$140K 0.03% 285
2022
Q3 		$1.07M Sell
12,612
-2,686
-18% -$239K 0.04% 260
2022
Q2 		$1.27M Sell
15,298
-4,528
-23% -$361K 0.04% 249
2022
Q1 		$1.53M Sell
19,826
-5,557
-22% -$465K 0.03% 254
2021
Q4 		$2.24M Sell
25,383
-6,364
-20% -$525K 0.04% 230
2021
Q3 		$2.45M Buy
31,747
+528
+2% +$41.7K 0.06% 211
2021
Q2 		$2.6M Buy
31,219
+3,671
+13% +$291K 0.08% 200
2021
Q1 		$2.08M Buy
27,548
+11,012
+67% +$900K 0.08% 197
2020
Q4 		$1.45M Buy
16,536
+10,504
+174% +$833K 0.07% 192
2020
Q3 		$459K Buy
6,032
+3,520
+140% +$356K 0.03% 320
2020
Q2 		$310K Buy
2,512
+1,287
+105% +$128K 0.05% 353
2020
Q1 		$104K Buy
1,225
+350
+40% +$30.2K 0.06% 256
2019
Q4 		$74K Buy
+875
New +$66.1K 0.02% 238

Other funds holding BMRN

Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
FWIA
Fort Washington Investment Advisors Cincinnati, Ohio $19.9B AUM 22.19% 1-Year Est. Return
RRAM
River Road Asset Management Louisville, Kentucky $8.99B AUM 12.83% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
PCM
Peregrine Capital Management Minneapolis, Minnesota $3.08B AUM 29.51% 1-Year Est. Return
CF
Covea Finance Paris, France $3.17B AUM 35.01% 1-Year Est. Return
AWM
Apollon Wealth Management Mount Pleasant, South Carolina $8.23B AUM 30.88% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
SAM
Secure Asset Management Troy, Michigan $714M AUM 27.91% 1-Year Est. Return

Exchange Traded Concepts's BMRN Position: Q2 2026 in Review

Exchange Traded Concepts increased its BioMarin Pharmaceuticals (BMRN) stake by 15% in Q2 2026, buying an estimated $145K and bringing the position to 19,898 shares worth $1.14M. The position accounts for 0.01% of the portfolio, ranked #888.

Exchange Traded Concepts first reported a position in BMRN in Q4 2019 and has held it in 27 quarters since. The position peaked at $2.6M in Q2 2021. 86 funds tracked by Wall St. Rank hold BMRN as of Q2 2026.

  • Exchange Traded Concepts held 19,898 shares of BioMarin Pharmaceuticals worth $1.14M as of Q2 2026.
  • Exchange Traded Concepts bought 2,644 BioMarin Pharmaceuticals shares in Q2 2026, an estimated $145K.
  • BioMarin Pharmaceuticals made up 0.01% of Exchange Traded Concepts's portfolio in Q2 2026, its #888 holding.
  • Exchange Traded Concepts first reported a position in BioMarin Pharmaceuticals in Q4 2019 and has held it in 27 quarters since.
  • Exchange Traded Concepts's BioMarin Pharmaceuticals position peaked at $2.6M in Q2 2021.
  • 86 funds tracked by Wall St. Rank held BioMarin Pharmaceuticals as of Q2 2026.

Based on Exchange Traded Concepts's 13F filing for Q2 2026, filed 22 Jul 2026.